Probiotics reduce insulin resistance and oxidative stress by increasing SOD (superoxide dismutase), GSH (glutathione), and catalase (CAT) activity, and reduce the expression of inflammatory cytokine tissue necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 [35,36]. The gene discussed is IL1B; the disease is Insulin resistance.